Results
|
|
1.
|
Anthracyclines in Early Breast Cancer: The ABC Trials-USOR 06-090, NSABP B-46-I/USOR 07132, and NSABP B-49 (NRG Oncology). MedStar authors:
Year: 2017
Citation: - Journal of Clinical Oncology. 35(23):2647-2655, 2017 Aug 10.
Institution: - Washington Cancer Institute
Medline publication type:
- Clinical Trial, Phase III
- Comparative Study
- Journal Article
- Randomized Controlled Trial
All authors: - Asmar L, Blum JL, Brufsky AM, Colangelo LH, Dang CT, Fehrenbacher L, Flynn PJ, Geyer CE Jr, Gomez HL, Hopkins JO, Jacobs SA, Jeong JH, Jones SE, Lyss AP, Mamounas EP, O'Shaughnessy JA, Paul D, Robert NJ, Swain SM, Vukelja SJ, Wolmark N, Yothers G
|
|
|
2.
|
|
|
|
3.
|
|
|
|
4.
|
|
|
|
5.
|
Low-Fat Dietary Pattern and Breast Cancer Mortality in the Women's Health Initiative Randomized Controlled Trial. MedStar authors:
Year: 2017
Citation: - Journal of Clinical Oncology. 35(25):2919-2926, 2017 Sep 01
Institution: - MedStar Health Research Institute
Medline publication type:
All authors: - Anderson GL, Aragaki AK, Barrington W, Chlebowski RT, Hou L, Howard BV, Lane D, Manson JE, Prentice RL, Qi L, Rohan TE, Simon MS, Snetselar L, Thomas F, Thomson CA, Vitolins MZ, Womack C
|
|
|
6.
|
Long-Term Follow-Up of the Anthracyclines in Early Breast Cancer Trials (USOR 06-090, NSABP B-46-I/USOR 07132, and NSABP B-49 [NRG Oncology]). MedStar authors:
Year: 2024
Citation: - Journal of Clinical Oncology. 42(12):1344-1349, 2024 Apr 20.
Department:
- Associate Dean for Research Development
- MedStar Health
Medline publication type:
All authors: - Geyer CE Jr, Blum JL, Yothers G, Asmar L, Flynn PJ, Robert NJ, Hopkins JO, O'Shaughnessy JA, Rastogi P, Puhalla SL, Hilton CJ, Dang CT, Gomez HL, Vukelja SJ, Lyss AP, Paul D, Brufsky AM, Colangelo LH, Swain SM, Mamounas EP, Wolmark N
|
|
|
7.
|
Reply to a. Avan et Al. MedStar authors:
Year: 2015
Citation: - Journal of Clinical Oncology. 33(15):1712, 2015 May 20.
Institution: - Washington Cancer Institute
Medline publication type:
All authors: - Baselga J, Clark E, Kiermaier A, Swain S
|
|
|
8.
|
Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. MedStar authors:
- Sugarbaker, Paul H
- Yan, Tristan D
Year: 2012
Citation: - Journal of Clinical Oncology. 30(20):2449-56, 2012 Jul 10.
Institution:
- MedStar Washington Hospital Center
- Washington Cancer Institute
Medline publication type:
- Journal Article
- Multicenter Study
- Research Support, Non-U.S. Gov't
All authors: - Baratti D, Barrios P, Ceelen WP, Chua TC, de Hingh IH, Deraco M, Elias D, Gilly FN, Glehen O, Gomez Portilla A, Gonzalez-Moreno S, Levine EA, Liauw W, Moran BJ, Morris DL, Pelz JO, Piso P, Sardi A, Sugarbaker PH, Van Der Speeten K, Yan TD
|
|
|
9.
|
Adjuvant tamoxifen reduces subsequent breast cancer in women with estrogen receptor-positive ductal carcinoma in situ: a study based on NSABP protocol B-24. MedStar authors:
Year: 2012
Citation: - Journal of Clinical Oncology. 30(12):1268-73, 2012 Apr 20.
Institution: - Washington Cancer Institute
Medline publication type:
- Comparative Study
- Journal Article
- Research Support, N.I.H., Extramural
- Research Support, Non-U.S. Gov't
All authors: - Allred DC, Anderson SJ, Costantino JP, Geyer CE Jr, Julian TB, Land SR, Mamounas EP, Nagtegaal ID, Paik S, Swain SM, Wickerham DL, Wolmark N
|
|
|
10.
|
Definitive results of a phase III adjuvant trial comparing three chemotherapy regimens in women with operable, node-positive breast cancer: the NSABP B-38 trial. MedStar authors:
Year: 2013
Citation: - Journal of Clinical Oncology. 31(26):3197-204, 2013 Sep 10.
Institution: - Washington Cancer Institute
Medline publication type:
- Clinical Trial, Phase III
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, N.I.H., Extramural
All authors: - Atkins JN, Azar CA, Biggs DD, Brufsky AM, Costantino JP, Donnellan PP, Fehrenbacher L, Geyer CE Jr, Levine EA, Mamounas EP, Northfelt DW, Paik S, Polikoff JA, Provencher L, Rastogi P, Robidoux A, Swain SM, Tang G, Wolmark N, Zapas JL
|
|
|
11.
|
Quality of life in MAP.3 (Mammary Prevention 3): a randomized, placebo-controlled trial evaluating exemestane for prevention of breast cancer. MedStar authors:
Year: 2014
Citation: - Journal of Clinical Oncology. 32(14):1427-36, 2014 May 10.
Institution: - MedStar Health Research Institute
Medline publication type:
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
All authors: - Ales-Martinez JE, Brundage M, Cheung AM, Chlebowski RT, Cooke AL, Dube P, Ellard SL, Fabian CJ, Gelmon KA, Goss PE, Hendrix S, Hiltz A, Ingle JN, Johnston D, Lickley L, Maunsell E, Pater JL, Pruthi S, Pujol P, Richardson H, Rowland KM, Ruiz A, Sarto GE, Spadafora S, Thayer DW, Tu D, Wactawski-Wende J
|
|
|
12.
|
Reply to E.J. Moylan et al. MedStar authors:
Year: 2014
Citation: - Journal of Clinical Oncology. 32(6):606-7, 2014 Feb 20.
Institution: - Washington Cancer Institute
Medline publication type:
All authors: - Geyer CE Jr, Swain SM, Tang G
|
|
|
13.
|
Safety and Activity of Immune Checkpoint Inhibitors in People Living With HIV and Cancer: A Real-World Report From the Cancer Therapy Using Checkpoint Inhibitors in People Living With HIV-International (CATCH-IT) Consortium. MedStar authors:
Year: 2023
Citation: - Journal of Clinical Oncology. 41(21):3712-3723, 2023 07 20.
Institution: - MedStar Washington Hospital Center
Department: - Internal Medicine Residency
Medline publication type:
All authors: - Abdallah W, Abdel-Wahab N, Aboubakar Nana F, Abu Ghazal B, Addeo A, Adib E, Al-Hader A, Arora A, Baden LR, Baena J, Bahary N, Baiocchi RA, Bakalov V, Bankapur A, Barletta G, Bersanelli M, Bower M, Chiao EY, Choueiri TK, Cortellini A, Dalla Pria A, Diab A, Dima D, Dittus C, Dizman N, Dobbs RW, Drakaki A, Drolen C, El Zarif T, El-Am E, Emu B, Falohun A, Fitzgerald BG, Florou V, Freeman D, Funchain P, Genova C, Hall E, Haykal T, Huang J, Idossa D, Johnson DB, Kim C, Kozaily E, Lamberti G, Lechner MG, Li M, Long GV, Lopetegui-Lia N, Lorentsen M, Lurain K, Mangla A, Marron TU, McKay RR, Menzies AM, Mittra A, Morse MA, Mouhieddine TH, Naqash AR, Nassar AH, Nebhan CA, Nonato T, Owen DH, Pinato DJ, Puri S, Queirolo P, Rajkumar A, Ramaswami R, Reed A, Reid EG, Rubinstein PG, Saeed A, Saleem R, Saponara M, Shah NJ, Shah V, Sharon E, Singh P, Sonpavde GP, Woodford R, Xie W
|
|
|
14.
|
Building bridges to conquer cancer. MedStar authors:
Year: 2013
Citation: - Journal of Clinical Oncology. 31(30):3731-6, 2013 Oct 20.
Institution: - Washington Cancer Institute
Medline publication type:
|
|
|
15.
|
Locoregional recurrence (LRR) after neoadjuvant chemotherapy (NAC): Pooled-analysis results from the Collaborative Trials in Neoadjuvant Breast Cancer (CTNeoBC). MedStar authors:
Year: 2014
Citation: - Journal of Clinical Oncology. 32(26_suppl):61, 2014 Sep 10
Institution: - Washington Cancer Institute
Medline publication type:
All authors: - Bogaerts J, Bonnefoi HR, Cameron DA, Cortazar P, Costantino JP, Eidtmann H, Gerber B, Geyer CE, Gianni L, Loibl S, Mehta K, Rastogi P, Sridhara R, Swain SM, Untch M, Valagussa P, Von Minckwitz G, Wolmark N, Zhang L
|
|
|
16.
|
|
|
|
17.
|
|
|
|
18.
|
|
|
|
19.
|
Organ Preservation in Patients With Rectal Adenocarcinoma Treated With Total Neoadjuvant Therapy. MedStar authors:
Year: 2022
Citation: - Journal of Clinical Oncology. :JCO2200032, 2022 Apr 28
Institution: - MedStar Washington Hospital Center
Department: - Surgery/Colorectal Surgery
Medline publication type:
All authors: - Bello BL, Carmichael JC, Cataldo P, Cercek A, Coveler AL, Dunne RF, Friel CM, Garcia-Aguilar J, Gleisner A, Gollub MJ, Goodman KA, Gregory A, Guillem JG, Herzig DO, Hunt S, Kim JK, Krauss J, Lee M, Lin S, Liska D, Marcet J, Nash GM, Omer DM, Oommen S, Pappou E, Patil S, Paty PB, Polite B, Saltz LB, Segal NH, Smith JJ, Temple L, Ternent C, Thompson HM, Varma MG, Verheij FS, Wei IH, Weiser MR, Widmar M, Wu AJ, Yaeger R, Yuval JB
|
|
|
20.
|
Avoiding a throwback to the past. MedStar authors:
Year: 2013
Citation: - Journal of Clinical Oncology. 31(3):396-7, 2013 Jan 20.
Institution: - MedStar Washington Hospital Center
Medline publication type:
|
|
|
21.
|
Trastuzumab plus adjuvant chemotherapy for human epidermal growth factor receptor 2-positive breast cancer: planned joint analysis of overall survival from NSABP B-31 and NCCTG N9831. MedStar authors:
Year: 2014
Citation: - Journal of Clinical Oncology. 32(33):3744-52, 2014 Nov 20.
Institution: - Washington Cancer Institute
Medline publication type:
- Journal Article
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
All authors: - Colon-Otero G, Davidson NE, Geyer CE Jr, Gralow J, Jeong JH, Mamounas E, Martino S, Perez EA, Rastogi P, Romond EH, Sledge G, Suman VJ, Swain SM, Winer EP, Wolmark N, Zujewski JA
|
|
|
22.
|
|
|
|
23.
|
Evaluation of lapatinib as a component of neoadjuvant therapy for HER2+ operable breast cancer: NSABP protocol B-41. MedStar authors:
Year: 2012
Citation: - Journal of Clinical Oncology. 30(18_suppl):LBA506, 2012 Jun 20
Institution: - Washington Cancer Institute
Medline publication type:
All authors: - Atkins JN, Azar CA, Baez-Diaz L, Bandos H, Bear HD, Brufsky A, Costantino JP, Farrar WB, Fehrenbacher L, Geyer CE, Kuebler JP, Mamounas EP, Margolese RG, Paik S, Rastogi P, Shibata HR, Swain SM, Tang G, Wolmark N
|
|
|
24.
|
NSABP B-38: Definitive analysis of a randomized adjuvant trial comparing dose-dense (DD) AC->paclitaxel (P) plus gemcitabine (G) with DD AC->P and with docetaxel, doxorubicin, and cyclophosphamide (TAC) in women with operable, node-positive breast cancer. MedStar authors:
Year: 2012
Citation: - Journal of Clinical Oncology. 30(18_suppl):LBA1000, 2012 Jun 20
Institution: - Medstar Franklin Square Medical Center
Medline publication type:
All authors: - Atkins JN, Azar CA, Biggs DD, Brufsky A, Costantino JP, Donnellan PP, Fehrenbacher L, Geyer CE, Levine EA, Mamounas EP, Paik S, Perez EA, Polikoff J, Provencher L, Rastogi P, Robidoux A, Tang G, Wolmark N, Zapas JL
|
|
|
25.
|
Updated Analysis of KEYNOTE-024: Pembrolizumab Versus Platinum-Based Chemotherapy for Advanced Non-Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score of 50% or Greater. MedStar authors:
Year: 2019
Citation: - Journal of Clinical Oncology. 37(7):537-546, 2019 03 01.
Institution: - Medstar Franklin Square Medical Center
Medline publication type:
All authors: - Brahmer JR, Csoszi T, Cuffe S, Fulop A, Gottfried M, Hotta K, Hui R, O'Brien M, Peled N, Pietanza MC, Rao S, Reck M, Riccio A, Robinson AG, Rodriguez-Abreu D, Tafreshi A, Vandormael K, Yang J
|
|
|
26.
|
Dietary Modification and Breast Cancer Mortality: Long-Term Follow-Up of the Women's Health Initiative Randomized Trial. MedStar authors:
Year: 2020
Citation: - Journal of Clinical Oncology. 38(13):1419-1428, 2020 05 01.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
All authors: - Anderson GL, Aragaki AK, Barac A, Chlebowski RT, Johnson KC, Lane DS, Luo J, Manson JE, Mossavar-Rahmani Y, Neuhouser ML, Pan K, Prentice RL, Rohan TE, Snetselaar L, Thomson CA, Wactawski-Wende J, Women's Health Initiative
|
|
|
27.
|
Trastuzumab Emtansine Plus Pertuzumab Versus Taxane Plus Trastuzumab Plus Pertuzumab After Anthracycline for High-Risk Human Epidermal Growth Factor Receptor 2-Positive Early Breast Cancer: The Phase III KAITLIN Study. MedStar authors:
Year: 2022
Citation: - Journal of Clinical Oncology. 40(5):438-448, 2022 02 10.
Department: - Associate Dean for Research Development
Medline publication type:
All authors: - Barrios C, Bonnefoi H, Boulet T, De Laurentiis M, Ellis PA, Fehrenbacher L, Gianni L, Gralow J, Harbeck N, Huang CS, Im SA, Im YH, Ito Y, Krop IE, Liu H, Macharia H, Nowecki Z, Shah J, Song C, Swain SM, Toi M, Trask P, Winer EP
|
|
|
28.
|
DPYD Testing: Time to Put Patient Safety First. MedStar authors:
- Smith, D Max
- Swain, Sandra M
Year: 2023
Citation: - Journal of Clinical Oncology. 41(15):2701-2705, 2023 May 20.
Department:
- Associate Dean for Research Development
- MedStar Health
- Pharmacogenomics
Medline publication type:
All authors: - Baker SD, Bates SE, Brooks GA, Dahut WL, Diasio RB, El-Deiry WS, Evans WE, Figg WD, Hertz DL, Hicks JK, Kamath S, Kasi PM, Knepper TC, McLeod HL, O'Donnell PH, Relling MV, Rudek MA, Sissung TM, Smith DM, Sparreboom A, Swain SM, Walko CM
|
|
|
29.
|
Phase II Study of Olaparib and Temozolomide for Advanced Uterine Leiomyosarcoma (NCI Protocol 10250). MedStar authors:
Year: 2023
Citation: - Journal of Clinical Oncology. :JCO2300402, 2023 Jul 19
Institution: - Washington Cancer Institute
Medline publication type:
All authors: - Allred JB, Attia S, Boikos SA, Bose S, Bui N, Burgess MA, Chen JL, Chen L, Close JL, Cote GM, D'Andrea A, Das B, Gano K, George S, Ingham M, Ivy SP, Kochupurakkal B, Marino-Enriquez A, Schwartz GK, Seetharam M, Shapiro GI, Thaker PH
|
|
|
30.
|
Patient-Reported Outcomes in OlympiA: A Phase III, Randomized, Placebo-Controlled Trial of Adjuvant Olaparib in gBRCA1/2 Mutations and High-Risk Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer. MedStar authors:
Year: 2024
Citation: - Journal of Clinical Oncology. 42(11):1288-1300, 2024 Apr 10.
Institution: - MedStar Franklin Square Medical Center
Medline publication type:
- Clinical Trial, Phase III
- Journal Article
- Randomized Controlled Trial
All authors: - Ganz PA, Bandos H, Spanic T, Friedman S, Muller V, Kuemmel S, Delaloge S, Brain E, Toi M, Yamauchi H, de Duenas EM, Armstrong A, Im SA, Song CG, Zheng H, Sarosiek T, Sharma P, Geng C, Fu P, Rhiem K, Frauchiger-Heuer H, Wimberger P, t'Kint de Roodenbeke D, Liao N, Goodwin A, Chakiba-Brugere C, Friedlander M, Lee KS, Giacchetti S, Takano T, Henao-Carrasco F, Virani S, Valdes-Albini F, Domchek SM, Bane C, McCarron EC, Mita M, Rossi G, Rastogi P, Fielding A, Gelber RD, Scheepers ED, Cameron D, Garber J, Geyer CE, Tutt ANJ
|
|
|
31.
|
|
|
|
32.
|
Biomarker analyses in CLEOPATRA: a phase III, placebo-controlled study of pertuzumab in human epidermal growth factor receptor 2-positive, first-line metastatic breast cancer. MedStar authors:
Year: 2014
Citation: - Journal of Clinical Oncology. 32(33):3753-61, 2014 Nov 20.
Institution: - Washington Cancer Institute
Medline publication type:
- Clinical Trial, Phase III
- Journal Article
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
All authors: - Baselga J, Clark E, Cortes J, Im SA, Kiermaier A, Ross G, Swain SM
|
|
|
33.
|
Intrinsic subtypes, PIK3CA mutation, and the degree of benefit from adjuvant trastuzumab in the NSABP B-31 trial. MedStar authors:
Year: 2015
Citation: - Journal of Clinical Oncology. 33(12):1340-7, 2015 Apr 20.
Institution: - Washington Cancer Institute
Medline publication type:
- Journal Article
- Research Support, N.I.H., Extramural
- Research Support, Non-U.S. Gov't
All authors: - Blackmon NL, Costantino JP, Fehrenbacher L, Finnigan M, Gavin PG, Geyer CE Jr, Jeong JH, Kim SR, Mamounas EP, Paik S, Pogue-Geile KL, Rastogi P, Song N, Swain SM, Wickerham DL, Wolmark N
|
|
|
34.
|
Prevention and Monitoring of Cardiac Dysfunction in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline. MedStar authors:
Year: 2017
Citation: - Journal of Clinical Oncology. 35(8):893-911, 2017 Mar 10
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
All authors: - Armenian SH, Barac A, Carver J, Constine LS, Denduluri N, Dent S, Douglas PS, Durand JB, Ewer M, Fabian C, Hudson M, Jessup M, Jones LW, Ky B, Lacchetti C, Lenihan D, Mayer EL, Moslehi J, Oeffinger K, Ray K, Ruddy K
|
|
|
35.
|
|
|
|
36.
|
Effect of intervention on a quality measure of pain management at Medstar Washington Cancer Institute. MedStar authors:
- Agrawal, Sundeep
- Chokshi, Puja
- Harkness, Jaylon
- Jang, Sekwon
- Self, Linda
- Wood, Lynne
- Yerasi, Charan
Year: 2014
Citation: - Journal of Clinical Oncology. 32(30_suppl):218, 2014 Oct 20
Institution:
- MedStar Washington Hospital Center
- Washington Cancer Institute
Department:
- Medicine/General Internal Medicine
- Quality Management
Medline publication type:
All authors: - Agrawal S, Chokshi P, Harkness J, Jang S, Self L, Wood L, Yerasi C
|
|
|
37.
|
Long-Term Follow-Up of Cardiac Function and Quality of Life for Patients in NSABP Protocol B-31/NRG Oncology: A Randomized Trial Comparing the Safety and Efficacy of Doxorubicin and Cyclophosphamide (AC) Followed by Paclitaxel With AC Followed by Paclitaxel and Trastuzumab in Patients With Node-Positive Breast Cancer With Tumors Overexpressing Human Epidermal Growth Factor Receptor 2. MedStar authors:
- Swain, Sandra M
- Zapas, John L
Year: 2017
Citation: - Journal of Clinical Oncology. 35(35):3942-3948, 2017 Dec 10
Institution: - Washington Cancer Institute
Medline publication type:
All authors: - Atkins JN, Biggs DD, Brufsky AM, Cecchini RS, Fehrenbacher L, Flynn PJ, Ganz PA, Geyer CE Jr, Gross HM, Jeong JH, Mamounas EP, Polikoff J, Rastogi P, Romond EH, Seay TE, Swain SM, Wade JL 3rd, Wahl TA, Wolmark N, Zapas JL
|
|
|
38.
|
Cancer-Related Cognitive Outcomes Among Older Breast Cancer Survivors in the Thinking and Living With Cancer Study. MedStar authors:
Year: 2018
Citation: - Journal of Clinical Oncology. :JCO1800140, 2018 Oct 03
Institution: - MedStar Washington Hospital Center
Medline publication type:
All authors: - Ahles T, Breen E, Carroll JE, Clapp J, Denduluri N, Dilawari A, Extermann M, Graham D, Holohan Nudelman K, Hurria A, Isaacs C, Jacobsen PB, Jim H, Kobayashi LC, Luta G, Mandelblatt JS, McDonald BC, Root J, Saykin AJ, Small BJ, Stern RA, Tometich D, Turner R, VanMeter JW, Zhai W, Zhou X
|
|
|
39.
|
Associations of Physical Activity With Survival and Progression in Metastatic Colorectal Cancer: Results From Cancer and Leukemia Group B (Alliance)/SWOG 80405. MedStar authors:
Year: 2019
Citation: - Journal of Clinical Oncology. :JCO1901019, 2019 Aug 13
Institution: - MedStar Washington Hospital Center
Medline publication type:
All authors: - Atkins JN, Blanke CD, Fuchs CS, Goldberg RM, Guercio BJ, Hochster HS, Innocenti F, Lenz HJ, Mayer RJ, Meyerhardt JA, Ng K, Niedzwiecki D, O'Neil BH, O'Reilly EM, Ou FS, Polite BN, Sato K, Shaw JE, Van Blarigan E, Venook AP, Zhang S
|
|
|
40.
|
Five-Year Outcomes With Pembrolizumab Versus Chemotherapy for Metastatic Non-Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score >= 50. MedStar authors:
Year: 2021
Citation: - Journal of Clinical Oncology. 39(21):2339-2349, 2021 07 20.
Institution: - MedStar Franklin Square Medical Center
Medline publication type:
All authors: - Brahmer JR, Csoszi T, Cuffe S, Fulop A, Gottfried M, Hotta K, Hui R, Jensen E, Leal TA, O'Brien M, Peled N, Pietanza MC, Rao S, Reck M, Riess JW, Robinson AG, Rodriguez-Abreu D, Tafreshi A, Zhao B
|
|
|
41.
|
|
|
|
42.
|
DPYD Testing: Time to Put Patient Safety First. MedStar authors:
- Smith, D Max
- Swain, Sandra M
Year: 2023
Citation: - Journal of Clinical Oncology. :JCO2202364, 2023 Feb 23
Department:
- Associate Dean for Research Development
- MedStar Health
- Pharmacogenomics
Medline publication type:
All authors: - Baker SD, Bates SE, Brooks GA, Dahut WL, Diasio RB, El-Deiry WS, Evans WE, Figg WD, Hertz DL, Hicks JK, Kamath S, Kasi PM, Knepper TC, McLeod HL, O'Donnell PH, Relling MV, Rudek MA, Sissung TM, Smith DM, Sparreboom A, Swain SM, Walko CM
|
|
|
43.
|
Long-Term Results of Organ Preservation in Patients With Rectal Adenocarcinoma Treated With Total Neoadjuvant Therapy: The Randomized Phase II OPRA Trial. MedStar authors:
Year: 2023
Citation: - Journal of Clinical Oncology. :JCO2301208, 2023 Oct 26
Institution: - MedStar Washington Hospital Center
Department: - Surgery/Colorectal Surgery
Medline publication type:
All authors: - Verheij FS, Omer DM, Williams H, Lin ST, Qin LX, Buckley JT, Thompson HM, Yuval JB, Kim JK, Dunne RF, Marcet J, Cataldo P, Polite B, Herzig DO, Liska D, Oommen S, Friel CM, Ternent C, Coveler AL, Hunt S, Gregory A, Varma MG, Bello BL, Carmichael JC, Krauss J, Gleisner A, Guillem JG, Temple L, Goodman KA, Segal NH, Cercek A, Yaeger R, Nash GM, Widmar M, Wei IH, Pappou EP, Weiser MR, Paty PB, Smith JJ, Wu AJ, Gollub MJ, Saltz LB, Garcia-Aguilar J
|
